期刊
BIOMEDICINES
卷 10, 期 11, 页码 -出版社
MDPI
DOI: 10.3390/biomedicines10112938
关键词
pregnancy; obstetric morbidity; fetal loss; antiphospholipid syndrome; antiphospholipid antibodies; non-criteria
This study compares the characteristics, features, serology, and outcomes of women with obstetric antiphospholipid syndrome (APS) to those with non-criteria (NC)-APS and seronegative (SN)-APS. The study found that the cardiovascular risk burden was higher in the APS group and patients with APS criteria received more intensive treatment. However, with the addition of standard of care (SoC) treatment, fetal-maternal outcomes were similar among all groups, with significant improvement in live births and a decrease in adverse pregnancy outcomes (APO).
This study aims to compare the demographic characteristics, clinical features, serology, and fetal-maternal outcomes between women with obstetric antiphospholipid syndrome (APS) and those with non-criteria (NC)-APS and seronegative (SN)-APS. Two-hundred and sixty-three women with APS obstetric morbidity ever pregnant were included. Of those, 66 met the APS classification criteria, 140 were NC-APS, and 57 were SN-APS. Patients with other autoimmune diseases were excluded. Adverse pregnancy outcomes (APO) included early pregnancy loss, fetal death, preeclampsia, abruptio placentae, and preterm birth. The mean age of the study group was 33.6 +/- 5.3 years, and patients were followed up for 129.5 +/- 81.9 months. In the NC-APS group, 31 (22.1%) did not fulfill clinical and serological criteria (Subgroup A), 49 (35%) did meet clinical but not serologic criteria (Subgroup B), and 60 (42.9%) fulfilled the serologic criteria but not the clinical ones (Subgroup C). The cardiovascular risk burden was higher in the APS group, due to a higher proportion of smoking. Patients with criteria APS received more intensive treatment than patients in the other study groups. The addition of standard of care (SoC) treatment significantly improved live birth and decreased APO in all groups. Significant clinical differences were observed between the study groups. However, when treated with SoC, fetal-maternal outcomes were similar, with a significant improvement in live births and a decrease in APO. Risk stratification in patients with obstetric morbidity associated with APS can help individualize their treatment.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据